Omega-3 (EPA/DHA)
Essential fatty acids from fish oil. Consistently lower triglycerides; effects on cardiovascular events depend on dose, formulation and population, and higher doses slightly raise the risk of atrial fibrillation.
Where to buy
-
iHerb California Gold Nutrition, Omega-3 Premium Fish Oil, 100 Fish Gelatin Softgels (1,100 mg per Softgel) Ships to 180+ countries · welcome discount for new customersView on iHerb
Each store sells its own product: check brand, amount and price on the store page before buying. Prices change; the date shows when we last checked.
Referral link — this site may earn a commission on purchases.
What the science says
- Triglyceride reduction Strong evidence
Doses of 2–4 g/day of EPA/DHA lower plasma triglycerides consistently and dose-dependently: about 15% on average across long-term trials, and 30% or more at 4 g/day in people with very high triglycerides.
- Who was studied
- 86 randomized trials lasting at least 12 months (162,796 adults at varying cardiovascular risk), plus the American Heart Association review of prescription-dose trials in people with high or very high triglycerides.
- Result
- Fasting triglycerides and other blood lipids.
- Effect size
- Long-chain omega-3 lowered triglycerides by about 15% in a dose-dependent way (high-certainty evidence); 4 g/day lowered very high triglycerides (500 mg/dL or more) by 30% or more, with EPA-only and EPA+DHA products roughly comparable.
- Limitations
- Triglycerides are a surrogate marker, and lowering them does not guarantee fewer heart attacks; EPA+DHA at 4 g/day can raise LDL cholesterol in people with very high triglycerides.
- Sources
- [1] [2]
- Cardiovascular protection Moderate evidence
Mixed results: REDUCE-IT showed fewer cardiovascular events with high-dose purified EPA (4 g/day) in high-risk patients on statins, but STRENGTH, with 4 g/day of EPA+DHA, found no benefit, and large meta-analyses show at most a small reduction in coronary events and little or no effect on overall mortality.
- Who was studied
- 8,179 statin-treated high-risk patients in REDUCE-IT, 13,078 in STRENGTH, and meta-analyses of 86 trials (162,796 participants) and 40 trials (135,267 participants).
- Result
- Major cardiovascular events, heart attacks, coronary events and all-cause mortality.
- Effect size
- REDUCE-IT: events in 17.2% vs 22.0% (HR 0.75, 95% CI 0.68 to 0.83); STRENGTH: 12.0% vs 12.2% (HR 0.99, 95% CI 0.90 to 1.09); Cochrane: all-cause mortality RR 0.97 (95% CI 0.93 to 1.01), coronary events RR 0.91 (95% CI 0.85 to 0.97), 167 people treated to prevent one event; second meta-analysis: heart attack RR 0.87 (95% CI 0.80 to 0.96).
- Limitations
- REDUCE-IT was funded by the drug's maker and tested a prescription EPA drug, so its result does not transfer to ordinary fish oil capsules; STRENGTH used corn oil as comparator, and the absolute benefit in lower-risk people is small.
- Sources
- [2] [3] [4] [5]
- Mood and cognition benefits Limited evidence
In diagnosed depression, omega-3 gives a small benefit that is probably not clinically meaningful and may be inflated by bias; EPA-rich formulas look better than DHA-rich ones. For memory and cognitive decline, the effect is at most modest.
- Who was studied
- 34 placebo-controlled trials with 1,924 adults with major depression; 26 trials with 2,160 participants with depressive symptoms; 14 trials with 26,881 adults aged 40 or older without dementia or with mild cognitive impairment.
- Result
- Depression rating scales, remission and response; cognitive scores on the MMSE.
- Effect size
- Depression SMD −0.40 (95% CI −0.64 to −0.16), about 2.5 points on the Hamilton scale where 3 points is the smallest meaningful change, with no difference in remission or response; formulas with at least 60% EPA did better (SMD −1.03) than DHA-rich ones; MMSE effect size 0.16 (95% CI 0.01 to 0.32).
- Limitations
- Cochrane rated the depression evidence very low certainty, with high heterogeneity and a likely bias toward positive results; the cognition result comes from an overview of reviews and is small and borderline.
- Sources
- [7] [8] [9]
- Higher risk of atrial fibrillation Moderate evidence
Long-term trials show that omega-3 supplements slightly raise the risk of atrial fibrillation, an irregular heart rhythm, and the risk grows with dose, especially above 1 g/day.
- Who was studied
- 7 cardiovascular outcome trials with 81,210 adults (mean age 65, 39% women) followed for about 4.9 years.
- Result
- New atrial fibrillation, reported as an outcome, adverse event or cause of hospitalization.
- Effect size
- HR 1.25 (95% CI 1.07 to 1.46) overall; 1.49 above 1 g/day versus 1.12 at 1 g/day or less, with risk rising about 11% per extra gram; in REDUCE-IT, hospitalization for atrial fibrillation was 3.1% vs 2.1%.
- Limitations
- Atrial fibrillation was not a primary outcome in most trials and the absolute increase is small; participants were older adults with cardiovascular risk, so the risk for young healthy users is less clear.
- Sources
- [6] [3]
Dosage & safety
How to take it
Interactions
With medications
- warfarin, DOACs, aspirin and clopidogrel
Fish oil has a mild antiplatelet effect that adds to anticoagulant and antiplatelet drugs, mainly at doses above 3 g/day. keep to 1 g/day or discuss higher doses with your prescriber, and stop before surgery
- blood pressure medication
Omega-3 lowers blood pressure modestly, which can add to antihypertensive drugs. usually helpful rather than harmful, but monitor if your pressure already runs low
With other supplements
- high-dose vitamin E
Both have antiplatelet activity; together the bleeding risk is greater than either alone. avoid combining high doses
- garlic extract and ginkgo biloba
Additive platelet inhibition. avoid stacking before surgery or on anticoagulants
Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.
Frequently asked questions
Does omega-3 fish oil lower triglycerides?
Yes — this is the strongest evidence for omega-3. Doses of 2–4 g/day of EPA/DHA lower triglycerides consistently, typically by 15–30%.
Does omega-3 prevent heart attacks?
The evidence for omega-3 and heart attacks is moderate and mixed. The REDUCE-IT trial found fewer cardiovascular events with 4 g/day of purified EPA in high-risk patients, but low-dose omega-3 supplements show little or no effect in the general population.
How much omega-3 per day?
For general health, take 1–2 g/day of combined EPA+DHA, with higher omega-3 doses only under medical guidance. Choose products with third-party purity certification.
Is fish oil safe with blood thinners?
Omega-3 fish oil has a mild antiplatelet effect that adds to warfarin, DOACs, aspirin and clopidogrel, mainly above 3 g/day. Keep to 1 g/day or discuss higher doses with your prescriber, and stop fish oil before surgery.
Scientific references
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
- Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial
- Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials
- Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
- Omega-3 fatty acids for depression in adults
- Efficacy of omega-3 PUFAs in depression: A meta-analysis
- Omega-3 Polyunsaturated Fatty Acids and Cognitive Decline in Adults with Non-Dementia or Mild Cognitive Impairment: An Overview of Systematic Reviews
Related in General health
- Vitamin D3 Strong evidence
- Vitamin B12 Strong evidence
- Multivitamin Limited evidence
- Iron Strong evidence
- Iodine Moderate evidence
- NAC (N-Acetylcysteine) Moderate evidence